20558148|t|Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol-induced catalepsy.
20558148|a|The inferior colliculus (IC) is primarily involved in the processing of auditory information, but it is distinguished from other auditory nuclei in the brainstem by its connections with structures of the motor system. Functional evidence relating the IC to motor behavior derives from experiments showing that activation of the IC by electrical stimulation or excitatory amino acid microinjection causes freezing, escape-like behavior, and immobility. However, the nature of this immobility is still unclear. The present study examined the influence of excitatory amino acid-mediated mechanisms in the IC on the catalepsy induced by the dopamine receptor blocker haloperidol administered systemically (1 or 0.5 mg/kg) in rats. Haloperidol-induced catalepsy was challenged with prior intracollicular microinjections of glutamate NMDA receptor antagonists, MK-801 (15 or 30 mmol/0.5 microl) and AP7 (10 or 20 nmol/0.5 microl), or of the NMDA receptor agonist N-methyl-d-aspartate (NMDA, 20 or 30 nmol/0.5 microl). The results showed that intracollicular microinjection of MK-801 and AP7 previous to systemic injections of haloperidol significantly attenuated the catalepsy, as indicated by a reduced latency to step down from a horizontal bar. Accordingly, intracollicular microinjection of NMDA increased the latency to step down the bar. These findings suggest that glutamate-mediated mechanisms in the neural circuits at the IC level influence haloperidol-induced catalepsy and participate in the regulation of motor activity.
20558148	44	58	NMDA receptors	GeneOrGeneProduct	24408
20558148	99	110	haloperidol	ChemicalEntity	D006220
20558148	119	128	catalepsy	DiseaseOrPhenotypicFeature	D002375
20558148	742	751	catalepsy	DiseaseOrPhenotypicFeature	D002375
20558148	767	784	dopamine receptor	GeneOrGeneProduct	24316
20558148	793	804	haloperidol	ChemicalEntity	D006220
20558148	851	855	rats	OrganismTaxon	10116
20558148	857	868	Haloperidol	ChemicalEntity	D006220
20558148	877	886	catalepsy	DiseaseOrPhenotypicFeature	D002375
20558148	948	971	glutamate NMDA receptor	GeneOrGeneProduct	24408
20558148	985	991	MK-801	ChemicalEntity	D016291
20558148	1023	1026	AP7	ChemicalEntity	C031231
20558148	1065	1078	NMDA receptor	GeneOrGeneProduct	24408
20558148	1087	1107	N-methyl-d-aspartate	ChemicalEntity	D016202
20558148	1109	1113	NMDA	ChemicalEntity	D016202
20558148	1200	1206	MK-801	ChemicalEntity	D016291
20558148	1211	1214	AP7	ChemicalEntity	C031231
20558148	1250	1261	haloperidol	ChemicalEntity	D006220
20558148	1291	1300	catalepsy	DiseaseOrPhenotypicFeature	D002375
20558148	1419	1423	NMDA	ChemicalEntity	D016202
20558148	1496	1505	glutamate	ChemicalEntity	D018698
20558148	1575	1586	haloperidol	ChemicalEntity	D006220
20558148	1595	1604	catalepsy	DiseaseOrPhenotypicFeature	D002375
20558148	Negative_Correlation	24316	D006220	No
20558148	Association	D018698	D002375	Novel
20558148	Association	D018698	D006220	Novel
20558148	Negative_Correlation	C031231	D002375	Novel
20558148	Negative_Correlation	C031231	D006220	Novel
20558148	Negative_Correlation	D016291	D002375	Novel
20558148	Negative_Correlation	D016291	D006220	Novel
20558148	Positive_Correlation	24408	D016202	No
20558148	Negative_Correlation	24408	C031231	No
20558148	Negative_Correlation	24408	D016291	No
20558148	Association	24408	D002375	Novel
20558148	Positive_Correlation	D006220	D002375	No